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Bio-based production of fatty acids and fatty acid-derived products
can enable sustainable substitution of petroleum-derived fuels and
chemicals. However, developing new microbial cell factories for
producing high levels of fatty acids requires extensive engineering
of lipid metabolism, a complex and tightly regulated metabolic
network. Here we generated a Saccharomyces cerevisiae platform
strain with a simplified lipid metabolism network with high-level
production of free fatty acids (FFAs) due to redirected fatty acid
metabolism and reduced feedback regulation. Deletion of the main
fatty acid activation genes (the first step in β-oxidation), main stor-
age lipid formation genes, and phosphatidate phosphatase genes
resulted in a constrained lipid metabolic network in which fatty acid
flux was directed to a large extent toward phospholipids. This
resulted in simultaneous increases of phospholipids by up to 2.8-
fold and of FFAs by up to 40-fold compared with wild-type levels.
Further deletion of phospholipase genes PLB1 and PLB2 resulted in
a 46% decrease in FFA levels and 105% increase in phospholipid
levels, suggesting that phospholipid hydrolysis plays an important
role in FFA production when phospholipid levels are increased. The
multiple deletion mutant generated allowed for a study of fatty
acid dynamics in lipid metabolism and represents a platform strain
with interesting properties that provide insight into the future de-
velopment of lipid-related cell factories.
phospholipids | free fatty acids | Saccharomyces cerevisiae |
metabolic engineering | CRISPR
Free fatty acids (FFAs) are versatile chemicals that can readilybe converted into a broad range of attractive industrial
compounds. FFAs are traditionally extracted from plant oils;
however, current engineering efforts aimed at creating a more
sustainable process are focusing on the development of microbial
cells capable of efficiently converting sugars into FFAs (1). With
a strong resistance to fermentation inhibitors and an ability to
survive at low pH levels, Saccharomyces cerevisiae is the pre-
ferred cell factory for industrial production of biochemicals (2,
3). It is an extensively well-studied organism with many available
genetic tools, such as the CRISPR/Cas9 technology for fast and
robust genome editing and pathway interference (4–7). Although
the capabilities of S. cerevisiae for fatty acid synthesis are limited
by strong intrinsic regulations, several attempts have been made
to produce FFAs using this organism as a host (8). This increases
the importance of understanding the dynamics of lipid metabo-
lism surrounding FFA biosynthesis.
In S. cerevisiae, fatty acids are synthesized by the fatty acid
synthetase complex encoded by FAS1 and FAS2, in which acetyl-
CoA and malonyl-CoA are iteratively processed to produce acyl-
CoA. Acyl-CoA formation is tightly regulated through allosteric
feedback inhibition of the acetyl-CoA carboxylase Acc1, re-
sponsible for malonyl-CoA production (9, 10). Acyl-CoAs from
fatty acid biosynthesis are esterified with a hydroxyl-containing
molecule (e.g., glycerol or sterol) to form major lipid classes,
such as triacylglycerols (TAGs), sterol esters (SEs), or phos-
pholipids. These three lipid classes represent the major pool of
fatty acyl chains in S. cerevisiae, accounting for most of the total
fatty acid-containing lipids in the cell, while other lipid classes
are detected only at very low levels (11, 12). In a wild-type cell,
FFAs are directly converted to acyl-CoA by fatty acyl-CoA syn-
thetases (13), a process that maintains low FFA levels in the
cytoplasm. Previous engineering strategies have shown that de-
letion of the two dominant acyl-CoA synthetase genes, FAA1 and
FAA4, results in deregulation of fatty acid biosynthesis and
overaccumulation of FFAs by orders of magnitude above that of
a wild-type strain (14–16). Characterization of these strains has
indicated that the FFAs originate from complex lipids (14), and
as such, are potentially a mere intermediary in lipid hydrolysis
and remodeling processes. This effect has been further explored
by combining the Δfaa1 Δfaa4 genotype with overexpression of
the pathway for accumulation and hydrolysis of TAGs (17).
While the foregoing mechanisms have been described and
consistently applied in FFA production, to date no studies have
properly explored the dynamics of FFA production in the
resulting strains in terms of the specific pathways and lipid spe-
cies involved in FFA formation. Furthermore, during the de-
velopment of fatty acid-overproducing cell factories, combinatorial
effects of modifications regarding fatty acid regulation might come
into play, which often are not being properly described or un-
derstood in the resulting strains.
Here we developed several strains to study FFA biosynthesis
by constraining the lipid metabolic network toward its essential
components, i.e., fatty acid and membrane lipid biosynthesis.
Analysis of the resulting strains allowed us to understand the role
of different lipid pools in FFA formation, as well as the effects of
up-regulating phospholipid biosynthesis and the existent re-
lationship between phospholipid and FFA levels in the cell.
Significance
Replacement of nonrenewable petrochemicals and liquid fuels
requires sustainable production of oleochemicals. Free fatty
acids (FFAs) are versatile molecules that can be produced by
microbial fermentation and are used as precursors for pro-
duction of these oleochemicals. In the past few years, we have
seen major advancements in improving the yeast Saccharo-
myces cerevisiae for FFA production. Despite these successes,
lipid metabolism is highly complex, and the pathways and
metabolites involved in the formation of FFAs in yeast remain
incompletely understood. In this work, we make important
advancements in understanding the dynamics of FFA forma-
tion in the cell and explore the role of phospholipids in
this process.
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Results
Deletion of Main Acyl-CoA Synthetases and Storage-Lipid Formation
Pathways Reveals That FFA Formation Is Independent of Storage
Lipids. To construct a strain for studying fatty acid dynamics
and fluxes, we removed the two dominant fatty acyl-CoA
synthetase-encoding genes, FAA1 and FAA4 (Fig. 1), which has
been previously shown to be sufficient to abolish FFA reac-
tivation, disrupt the FFA feedback regulation loop, and de-
regulate fatty acid biosynthesis (13, 18). Removal of these two
genes resulted in the RP01 strain that produced 35 mg·gDCW1
of FFAs in batch culture (Fig. 2), more than 10-fold compared
with the control strain. To prevent FFA and acyl-CoA degra-
dation and provide a more constrained lipid metabolism net-
work, we deleted the fatty acyl-CoA oxidase encoded by POX1,
which catalyzes the first step of the β-oxidation pathway located
in the peroxisomes and is nonessential for growth on glucose
(19, 20). POX1 deletion from the RP01 strain, resulting in
strain RP02, led to a 58% increase in produced FFAs, to
53 mg·gDCW−1 (Fig. 2).
To investigate the role of neutral lipids in FFA formation, we
removed fatty acid accumulation in the form of storage lipids by
deleting the two main genes responsible for TAG formation—
DGA1, encoding diacylglycerol acyltransferase, and LRO1,
encoding phospholipid:diacylglycerol acyltransferase—and the
two main genes responsible for sterol-ester formation—ARE1
and ARE2, encoding acyl-CoA:sterol acyltransferases (Fig. 1).
Progressive deletion of the major genes responsible for storage
lipid formation resulted in the strain RP09 (Δfaa1 Δfaa4 Δpox1
Δdga1 Δlro1 Δare1 Δare2), which did not show significant dif-
ferences in FFA production levels compared with RP02
(53 mg·gDCW−1 and 57 mg·gDCW−1, respectively; P > 0.05).
These results suggest that even though storage lipids may have
a role in FFA formation, these are not key intermediaries, since
RP09 is devoid of TAGs and SEs (Fig. S1) and does not present
a major deficiency in FFA formation compared with RP02 (Fig.
2). Even though previous studies have shown that FFAs can be
effectively produced using storage lipids as an intermediary (17),
our results show that there is an alternative native pathway ca-
pable of carrying high fluxes of FFA formation that does not rely
on storage lipid synthesis.
Deletion of Phosphatidate Phosphatases Increases the Levels of FFAs
and Phospholipids. Use of the strain RP09 allowed for further
study of the fatty acid dynamics and pathways involved in FFA
formation, since it is devoid of neutral lipids, and thus these
could be excluded from the fatty acid pools existent in the cell.
According to previous studies, the removal of TAG formation
through DGA1 and LRO1 deletion leads to an accumulation of
diacylglycerols (DAGs) (21). DAGs are formed mainly through
dephosphorylation of phosphatidic acid (PA), which is an es-
sential precursor for formation of other phospholipid species.
PA has also been characterized as an important signaling mol-
ecule for regulation of lipid metabolism. High levels of PA lead
to reduced translocation of the transcriptional regulator Opi1 to
the nucleus (22), preventing its binding to the transcription
factor Ino2. Since Ino2 is an activator of many fatty acid and
phospholipid biosynthesis genes, an increase in PA levels in-
directly causes an up-regulation of the fatty acid biosynthesis
machinery (Fig. 3B) (23–25).
To evaluate the effects of up-regulating fatty acid and lipid
biosynthesis in this strain and further constrain the network of
fatty acid fluxes, we aimed to remove dephosphorylation of PA
to DAG (Fig. 3A), which would allow for PA accumulation and
therefore interfere with Opi1-mediated regulation. PA de-
phosphorylation is catalyzed by phosphatidate phosphatases
encoded mainly by PAH1, LPP1, and DPP1, and as such, these
genes were deleted from RP09, resulting in the strain MLM1.0.
Deletion of PAH1, LPP1 and DPP1 led to an increase in total
FFAs to 102 mg·gDCW−1, a 98% increase compared with the
previous strain RP09 (Fig. 3 C and E). While levels of both
saturated and unsaturated FFAs were increased in MLM1.0,
analysis of the FFA composition showed that the percentage
of unsaturated (C16:1 and C18:1) compared with saturated
(C16:0 and C18:0) FFAs decreased from 62% in RP09 to 56% in
MLM1.0. Removal of the phosphatidate phosphatases resulted
in exclusive use of PA for phospholipid biosynthesis (Fig. 3A)
by removing the conversion of PA to DAG. As a result of this
flux constraint and the deregulation through PA signaling,
phospholipid levels were increased to 30 mg·gDCW−1, an
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Fig. 1. Simplified schematic representation of key lipid metabolism fluxes
and genes in S. cerevisiae. Highlighted in red are genes targeted for deletion
in the RP09 strain: fatty acyl-CoA synthetases FAA1 and FAA4, fatty acyl-CoA
oxidase POX1, diacylglycerol acyltransferase DGA1, phospholipid:diacylglycerol
acyltransferase LRO1, and acyl-CoA:sterol acyltransferases ARE1 and ARE2. The
lipid species quantified experimentally are in dark blue. PA, phosphatidic acid;
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Fig. 2. Effect of disrupting lipid droplet formation on total FFA levels. Total
(intracellular and extracellular) FFAs were quantified for the different
knockout strains lacking fatty acid reactivation (FAA1 and FAA4 deletions),
β-oxidation (POX1 deletion), and storage lipid formation (DGA1, LRO1,
ARE1, and ARE2 deletion). Strains were grown for 72 h in minimal medium
containing 2% glucose, and FFAs were quantified from biological triplicates.
**P < 0.005 (Student’s t test, two-tailed, two-sample equal variance).
Differences between RP03-09 and RP02 were statistically nonsignificant
(P > 0.05).
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eightfold increase compared with RP09 (Fig. 3D). The phos-
pholipid fraction was composed mostly of phosphatidylcholine,
which accounted for 54% of the total phospholipids, and a
similar percentage of phosphatidylethanolamine (PE) and
phosphatidylinositol (PI), which accounted for 22% and 21%,
respectively. Phosphatidylserine and cardiolipin were present
only in low percentages, respectively 2% and 1% of total phos-
pholipids (Fig. 3 D and E).
Since deregulation of Opi1-controlled phospholipid biosyn-
thesis genes has been previously associated with an expansion of
internal ER and nuclear membrane structures (26–28), we per-
formed transmission electron microscopy (TEM) on the main
strains, and observed formation of large membrane structures in
MLM1.0 that were not observed in the RP02 or RP09 strains
(Fig. S2). Furthermore, several stacked membrane sheets were
observed in the enlarged ER structure. For strain MLM1.0, ag-
gregates were observed in the medium supernatant after sepa-
ration of cells by centrifugation. These aggregates could be
stained by BODIPY and Nile Red, both fluorescent dyes specific
toward lipids (Fig. S3). We speculated that accumulation of
phospholipids disturbs membrane formation, ultimately leading
to the formation of lipid aggregates in the extracellular medium;
however, due to difficulties in isolating these aggregates, extensive
characterization could not be carried out. In addition, while not
detected in RP09, generation of the strain MLM1.0 resulted in a
recurrence of SEs up to 11 mg·gCDW−1 in MLM1.0 (Fig. S1).
Further investigation through colony PCR indicated incomplete
removal of the gene due to the complexity of the genomic region,
potentially indicating remaining activity of the ARE2 gene, and
therefore a flux through this enzyme to SE synthesis. Final bio-
mass values for MLM1.0 were decreased compared with the other
strains tested. In minimal medium with 2% glucose, MLM1.0
reached biomass values of 5.8 g/L, compared with 6.6 g/L for RP09
and 8.5 g/L for the control strain (Table S1).
Phospholipases B Play a Major Role in FFA Formation in MLM1.0.
Through the process of constraining the lipid metabolic net-
work, we observed a simultaneous increase in both phospholipids
and FFAs, suggesting the existence of a link between the two
lipid groups. Thus, we hypothesized that the FFAs in MLM1.0
are generated mainly through hydrolysis of phospholipids
through phospholipases, and that an increased phospholipid
content would consequently result in higher FFA levels. The
class of phospholipases with a potential role to alter the FFA
levels are phospholipases A and B as they cleave the acyl chain at
the sn-1 and sn-2 positions from the glycerol backbone. Phos-
pholipases B are characterized as enzymes that sequentially
remove fatty acyl groups at both sn-1 and sn-2, in contrast to
phospholipases A, which cleave uniquely at either sn-1 or sn-2.
Plb1, Plb2, Plb3, and Nte1 are known to exhibit phospholipase B
activity (29, 30). As such, we aimed to validate the hypothesis
that FFAs are mostly generated from phospholipid hydrolysis
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Fig. 3. Effect of deleting the main phosphatidate phosphatases on the FFA levels. (A) Schematic representation of the main reactions forming and con-
suming PA. Highlighted in red are the genes deleted for removal of phosphatidate phosphatase activity (PAH1, DPP1, and LPP1). (B) Signaling mechanism
linking PA accumulation and the up-regulation of fatty acid biosynthesis through Opi1. PA binds to Opi1, which indirectly causes an up-regulation of ACC1,
FAS1, and FAS2 genes. (C) Total FFA quantification of MLM1.0 compared with strains RP09, RP02, and the control strain (wt). (D) Storage lipid and phos-
pholipid levels in strains RP02, RP09, and MLM1.0 compared with the wild-type control strain. (D) Phospholipid levels in strains RP09, MLM1.0, and MLM1.0 +
Δplb1 Δplb2. PC, phosphatidylcholine; PE, phosphatidylethanolamine; PI, phosphatidylinositol; PS, phosphatidylserine. (E) Summary table of genes deleted in
each of the evaluated strains. Strains were grown for 72 h in minimal medium containing 2% glucose and all experiments were performed with five biological
replicates. **P value < 0.005 (Student’s t test: two-tailed, two-sample equal variance).
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through deletion of the genes encoding the two major phos-
pholipases, PLB1 and PLB2 (Fig. 4A). This deletion resulted
in a decreased level of the total FFA levels by 46%, to
55 mg·gDCW−1 (Fig. 4B). The percentage of unsaturated FFAs
between MLM1.0 and MLM1.0 Δplb1 Δplb2 decreased from
62% to 40% (Fig. 4C), indicating that removal of PLB1 and
PLB2 hindered the flux of unsaturated FFA formation more
than saturated FFA formation. At the same time, these dele-
tions led to an accumulation of total phospholipids up to
61 mg·gDCW−1, a twofold increase compared with MLM1.0
(Fig. 4D).
Phospholipid composition changed slightly on deletion of
PLB1 and PLB2 from MLM1.0; phosphatidylcholine was re-
duced to 47%, while PI and PS increased to 26% and 4%, re-
spectively. The PE percentage remained the same at 22% of
total phospholipids (Fig. 4E). This might point toward a higher
preference of Plb1 and Plb2 toward PI and PS hydrolysis. The
simultaneous decrease in FFA levels and increase in phospho-
lipid levels on deletion of the phospholipase genes PLB1 and
PLB2 strongly indicates that a significant portion of FFAs in
MLM1.0 is generated through phospholipid hydrolysis. Fur-
thermore, previous studies have shown that phospholipids in
S. cerevisiae mostly incorporate unsaturated fatty acids in both
the sn-1 and sn-2 positions (11), and as such, the decrease in
unsaturated FFA supports the hypothesis of FFA formation
through phospholipid hydrolysis. Analysis of total fatty acid
content in the cell suspension through derivatization of free and
bound fatty acids shows similar values of 175 mg·gDCW−1 and
180 mg·gDCW−1 between MLM1.0 and MLM1.0 Δplb1 Δplb2,
respectively, with similar distributions regarding chain length and
saturation levels (Fig. S4). These similarities in fatty acid com-
position while the lipid class distribution is significantly changed
(Fig. S1) highly suggest that the fatty acid synthesis machinery is
not altered when PLB1 and PLB2 are deleted. Here we speculate
that it is instead the conversion of phospholipids into other lipid
classes, namely FFAs, that is affected. TEM of MLM1.0 Δplb1
Δplb2 did not show a major difference in accumulation of enlarged
intracellular membrane structures; however, we observed that
several cells showed a more compact and stacked morphology of
these enlarged structures, as opposed to the single large-volume
structures observed in MLM1.0 (Fig. S2). This is possibly due to
changes in phospholipid composition, such as the change of ratio
in saturated to unsaturated fatty acids, which might affect the
capability of membrane bending and lead to the formation of
particular structures (31, 32).
To investigate whereas Plb1 and Plb2 also play roles in FFA
formation in a strain, in which storage lipids and lipid drop-
lets are fully present, and the deregulation of Opi1-controlled
phospholipid biosynthesis genes is not applied, we deleted
PLB1 and PLB2 also in the RP02 strain and evaluated the levels
of FFAs in that strain. Deletion of both genes resulted in
33 g·gDCW−1, a 20% decrease in FFA levels compared with
RP02. This confirms the relevance of phospholipases B in FFA
formation and phospholipids as a main precursor for generated
FFAs (Fig. S5).
FFA Levels Are Not Affected by Phospholipase Overexpression. Be-
cause phospholipid accumulates in MLM1.0 even when high
production of FFAs is observed, we wanted to further investigate
if FFA formation from phospholipids was limited by phospho-
lipase activity. As such, we individually overexpressed three dif-
ferent phospholipase B genes: PLB1, PLB2, and PLB3 (Fig. 5A).
For this, we used a multicopy plasmid expressing the genes under
the control of a strong constitutive TEF1 promoter. Surprisingly,
overexpression of these phospholipases resulted in a maximum
increase in total FFA production of only 16% for PLB2 (P values
for PLB1, PLB2, and PLB3 > 0.05) (Fig. 5B). This result suggests
that phospholipase activity might not be a major limiting step in
FFA production. To further investigate if flux-limiting steps exist
elsewhere downstream of acyl-CoA biosynthesis, we expressed a
truncated version of the Escherichia coli thioesterase gene tesA
(’tesA). Thioesterase overexpression in this strain allows for FFA
production directly through the hydrolysis of fatty acyl-CoA. This
creates a pathway alternative to the phospholipid-mediated
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pathway, thereby allowing for production of FFAs independent
of the phospholipid production/hydrolysis cycle (Fig. 5A). Ex-
pression of the thioesterase ‘TesA improved FFA production by
26% up to 129 mg·gDCW−1 (Fig. 5B) with statistical significance
(P < 0.05). This significant increase in FFA from expression of a
thioesterase with expression of phospholipases not resulting in
the same increase points toward a flux control at the level of the
phospholipid biosynthesis pathway from acyl-CoA rather than a
limitation in fatty acid biosynthesis capabilities.
Discussion
Regulating levels of different lipid pools is an evolutionary ad-
vantage for a yeast cell, providing the capacity to adapt to dif-
ferent environments or carbon source availability and resistance
to stresses. However, as a chassis for cell factory development
and metabolic engineering, a complex metabolic network entwined
with tight regulation mechanisms can offer many challenges and
difficulties for progress. Here we have engineered the lipid me-
tabolism of S. cerevisiae by removing many reactions involved in
the production of storage lipids, fatty acid oxidation, and conver-
sion of FFAs to fatty acyl-CoA. The combined deletions not only
were relevant in reducing the complexity of the metabolic network,
but also disrupted several lipid regulation mechanisms. Strains
resulting from constraining the lipid metabolic network and redi-
recting fatty acid fluxes toward phospholipids showed increases in
both FFAs and phospholipids, suggesting a strong correlation
between the two. Characterization of the resulting strain MLM1.0
points strongly toward phospholipid hydrolysis as a major path-
way for FFA formation, identifying phospholipases B as the key
players in this process.
The process of deregulating fatty acid and phospholipid bio-
synthesis genes led to significant changes in the distribution and
total levels of most analyzed lipid classes. It also caused severe
morphological changes in the internal membrane structure.
Taken together, our results highlight the complexity of entwined
metabolic and regulatory networks found in S. cerevisiae lipid
metabolism. By identifying the different factors that come into
play and how the lipid species are redistributed in the cell on the
redirection of lipid metabolism, we believe to have contributed
important information toward understanding the effects that
emerge when S. cerevisiae is engineered at the level of lipid
metabolism.
While the strains developed in this study strongly contribute to
fundamental insights into FFAs dynamics, they can also serve as
a tool for the development of S. cerevisiae as a cell factory for the
production of FFAs and fatty-acid derived products. One of the
favorable traits of S. cerevisiae is its capacity to accumulate
high levels of precursors without the tight feedback regulation
mechanisms present in lipid metabolism and the lack of major
competing reactions for acyl-CoA. Furthermore, the strain was
developed through scarless deletions, without the use of re-
sistance markers or other common genetic elements. This offers
major advantages for further studies, because it does not limit
genome editing options. Along with the advantages of reduced
complexity of the lipid metabolic network with improved regu-
lation, the strain also has the benefit of not carrying any over-
expression, which means that the strain is not suffering from a
protein burden. On the contrary, through the deletion of several
genes, it may be possible to allocate proteome mass for the ex-
pression of heterologous pathways that further convert the FFAs
to other valuable products, such as fatty alcohols, olefins,
or alkanes.
Methods
Plasmid Construction and Strain Construction. The plasmids, strains, and pri-
mers used in this study are listed in Dataset S1. Oligonucleotides were or-
dered from Eurofins. All fragments obtained by PCR were gel- or column-
purified (GeneJET Gel and PCR Clean-up columns) before cloning, and the
resulting plasmids were verified by sequencing (Eurofins). Yeast transfor-
mations were performed using lithium acetate and PEG3350 (33). Gene
deletions were performed in the strain IMX581 using CRISPR/Cas9 as de-
scribed previously (34). The diagnostic primers and the repair frag-
ments (listed in Dataset S1) were designed using the Yeastriction webtool
(yeastriction.tnw.tudelft.nl/), with the exception of the PLB1 and PLB2 de-
letions, which were carried out with a single gRNA promiscuously targeting
both PLB1 and PLB2, as described previously (35).
Media and Culture Conditions. S. cerevisiae strains with auxotrophies were
grown on YPD plates containing 20 g·L−1 glucose, 10 g·L−1 yeast extract,
20 g·L−1 peptone from casein, and 20 g·L−1 agar. Plasmid-carrying strains
were grown on selective growth medium containing 6.9 g·L−1 yeast nitrogen
base without amino acids (Formedium), 0.77 g·L−1 complete supplement
mixture without uracil (Formedium), 20 g·L−1 glucose, and 20 g· L−1 agar.
Shake flask cultivations were performed in minimal medium containing
20 g·L−1 glucose, 5 g·L−1 (NH4)2SO4, 14.4 g·L
−1 KH2PO4, and 0.5 g·L
−1
MgSO4·7H2O. After sterilization, 2 mL·L
−1 of trace element solution and
1 mL·L−1 of vitamin solution were added. The compositions of the trace el-
ement and vitamin solution have been reported previously (36). All experi-
ments were performed with strains cultivated as biological replicates, that is,
five independent transformants were used to start the precultures.
Quantification of Lipids. Samples for lipid analysis were obtained as 10–15 mL
of culture at the end of the shake flask cultivations, after 72 h. Subsequently,
the samples were centrifuged at 3,000 × g for 5 min, after which the su-
pernatant was discarded. The pellets were kept at −20 °C for 5 min and then
freeze-dried in a Christ Alpha 2–4LSC laboratory freeze drier (Christ
Gefriertrocknungsanlagen). The samples were analyzed using 10 mg of
dried cell biomass as described previously (12).
Quantification of FFAs. FFAs were simultaneously extracted and methylated
by dichloromethane containing methyl iodide as a methyl donor (37). In
brief, 100-μL aliquots of whole cell culture (cells + supernatant) were
placed into glass vials and diluted with 100 μL of water. Then 10 μL 40%
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Fig. 5. Effect of overexpressing phospholipase genes PLB1, PLB2, and PLB3
and a thioesterase gene ‘tesA in strain MLM1.0. (A) Representation of the
most significant fatty acid metabolism fluxes in MLM1.0. The genes over-
expressed in this experiment are highlighted In green. (B) Total FFA quan-
tification of MLM1.0 expressing either phospholipase genes PLB1, PLB2,
PLB3, or a thioesterase gene ‘tesA from a 2 μ multicopy plasmid under
control of the TDH3 (GPD) promoter. The empty plasmid served as a control.
Strains were grown for 72 h in minimal medium containing 2% glucose, and
FFA quantification was performed with biological triplicates. *P < 0.05
(Student’s t test; two-tailed, two-sample equal variance). Differences be-
tween MLM1.0-PLB1/2/3 and MLM1.0 (empty plasmid) were statistically
nonsignificant (P > 0.05).
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tetrabutylammonium hydroxide (base catalyst) was added, followed im-
mediately by the addition of 200 μL of dichloromethane containing
200 mM methyl iodide as methyl donor and 100 mg·L−1 pentadecanoic acid
as an internal standard. The mixtures were shaken for 30 min at 1,400 rpm
using a vortex mixer, and then centrifuged at 5,000 × g to promote phase
separation. A 160-μL dichloromethane layer was transferred into a gas
chromatography (GC) vial with a glass insert, and then evaporated for
30 min to dryness. The extracted methyl esters were resuspended in 200 μL
of hexane and then analyzed by GC (Focus GC; Thermo Fisher Scientific)
equipped with a Zebron ZB-5MS capillary column with GUARDIAN (30 m ×
0.25 mm × 0.25 μm; Phenomenex) and a flame ionization detector (FID;
Thermo Fisher Scientific). The GC program was as follows: initial temper-
ature of 50 °C, hold for 2 min; ramp to 140 °C at a rate of 30 °C/min, then
raised to 280 °C at a rate of 10 °C/min and hold for 3 min. The temperature
of the inlet was maintained at 280 °C. The injection volume was 1 μL. The
flow rate of the carrier gas (helium) was set to 1 mL·min−1. Final quanti-
fication was performed using Xcalibur software.
Quantification of Total Fatty Acid Content. Samples for total (bound and free,
intracellular and extracellular) fatty acid analysis were taken as 1 mL of
culture at the end of 72-h shake flask cultivations. The 1-mL culture volume
was kept at −80 °C for 5 min and then freeze-dried in a Christ Alpha 2–4LSC
for 3 d. The total lyophilized culture was processed for fatty acid extraction
and derivatization to methyl esters as described previously (38). Samples
were resuspended in 1 mL of hexane and analyzed with a gas chromato-
graph (Focus GC; Thermo Fisher Scientific) equipped with a Zebron ZB-5MS
capillary column with GUARDIAN (30 m × 0.25 mm × 0.25 μm; Phenomenex)
and an FID using the GC program as described previously (38). Final quan-
tification was performed using Xcalibur software.
Lipid Staining. After 72 h of shake flask culture, 100 μL of cell culture was
transferred to a 1.5-mL Eppendorf tube, centrifuged, and washed with 1 mL
of deionized water. Cells were then centrifuged at 3,000 × g for 5 min and
resuspended in 100 μL of PBS. Resuspended cells were treated with 1 μL
of BODIPY 493/503 solution (1 mg·mL−1 in ethanol; Thermo Fisher Scientific),
3 μL Nile Red (1 mg·mL−1 in DMSO), or 0.5 μL Calcofluor White M2R
(1 mg·mL−1 stock solution; Sigma-Aldrich) and kept at 4 °C in the dark for
10 min. Fluorescent microscope pictures were analyzed using a Leica
DMI4000B inverted microscope and processed with Leica Application Suite
(LAS) software.
TEM. The samples were prepared as described previously 39. In brief, after
fixation with glutaraldehyde 2% in cacodylate buffer for 45 min at 4 °C, the
yeast cells were treated with Lyticase (Sigma-Aldrich) for 30 min at 37 °C and
postfixed with osmium tetroxide 2%, to gently soften the cell wall. Then the
samples were dehydrated and embedded in epoxy resin (Agar 100). Ultra-
thin sections (70 nm) were imaged with a Leo Gemini transmission electron
microscope (Zeiss).
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